News & Research Feed

Retatrutide News & Research

Latest peer-reviewed retatrutide research, trial results, and regulatory updates.

All Retatrutide Tirzepatide Semaglutide Peptide Therapy FDA Updates Clinical Trials Editorial

PubMed Retatrutide

Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies

Lempesis IG, Dalamaga M — Metabolism open

2026-06-01 Read source →

PubMed Retatrutide

GIPR:GCGR co-agonism restores normal weight in obese rodents

Perez-Tilve D, Zhang F, Zhang Y, et al. — Molecular metabolism

2026-04-15 Read source →

PubMed Retatrutide

Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair

Li Q, Cheng W, Zhang J, et al. — Diabetology & metabolic syndrome

2026-04-10 Read source →

PubMed Retatrutide

Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions

Lian J, Lareu RR, Patil M, et al. — Liver international : official journal of the International Association for the Study of the Liver

2026-04-01 Read source →

PubMed Retatrutide

Retatrutide in type 2 diabetes mellitus and obesity: an overview

Panou T, Gouveri E, Popovic DS, et al. — Expert review of clinical pharmacology

2026-04-01 Read source →

PubMed Retatrutide

Childhood obesity and cardiac risk in youth: Emerging challenges toward 2050

Mishra NK — Clinical nutrition ESPEN

2026-03-31 Read source →

PubMed Retatrutide

New Drugs on the Block: Dietary Management and Nutritional Considerations During the Use of Anti-Obesity Medication

Pardali EC, Gkouskou KK, Cholevas C, et al. — Nutrients

2026-03-18 Read source →

PubMed Retatrutide

Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes

Malandris K, Charalampidis K, Loomba R, et al. — Current diabetes reports

2026-03-14 Read source →

PubMed Retatrutide

Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials

Abulehia A, Ayesh H, Ayesh O, et al. — Endocrinology, diabetes & metabolism

2026-03-01 Read source →

PubMed Retatrutide

Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models

Briand F, Le Cudennec C, Grasset E, et al. — Obesity (Silver Spring, Md.)

2026-02-25 Read source →

Sources & methodology. Items aggregated from public scientific and regulatory sources: PubMed (NCBI E-utilities), FDA press releases, and ClinicalTrials.gov v2 API. Summaries are factual excerpts from source records — no editorial commentary. Inclusion does not imply endorsement, and items are not medical advice. Last regenerated: 2026-04-26.